Overview

Effect of Vecam 40/300 and Vecam 20/300 Compared to Omeprazole 20 mg on Gastric pH

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The study is designed to assess and compare the effect of Vecam 40/300, Vecam 20/300 and Omeprazole 20 mg (a standard FDA approved GERD treatment) on the control of gastric pH.
Phase:
Phase 1
Details
Lead Sponsor:
Vecta Ltd.
Treatments:
Omeprazole